Market Overview:
The global nebulizers and inhalers market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, such as COPD, cystic fibrosis, and asthma. In addition, the growing geriatric population is also contributing to the growth of this market. The nebulizers segment is expected to dominate the global nebulizers and inhalers market during the forecast period owing to their high usage in hospitals and clinics for treating respiratory diseases. However, with technological advancements being made in inhalers segment, it is expected that this segment will grow at a higher CAGR than that of nebulizers during the forecast period.
Product Definition:
Nebulizers and inhalers are devices that help deliver medication to the lungs. Nebulizers turn medication into a mist that is inhaled through a mask or mouthpiece. Inhalers release medication in a spray form that is breathed in through the mouth. Nebulizers and inhalers are used to treat conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis.
Nebulizers:
Nebulizers and inhalers are respiratory devices used to inhale or inject a drug into the lungs. Nebulizers are more popular as they help in delivering drugs to patients who cannot take an oral dose. They work by expanding the gas that carries the medicine into the air where it is absorbed by the lungs.
The nebulizer market is expected to grow at a significant rate owing to increasing demand for home healthcare, aging population, technological advancements such as wireless technology.
Inhalers:
Inhalers are devices used to inhale medications. They are more convenient and flexible than nebulizers as they can be used at home, in the office, or on the go. Inhalers come in two forms - dry powder inhaler (DPI) and metered dose inhaler (MDI). DPI is a pre-filled container that contains medication which can be inhaled by pressing a button.
Application Insights:
The others segment held the largest share of over 50.0% in 2017. The application includes allergic rhinitis, sinusitis, and other nasal congestion disorders. Increasing awareness about asthma is one of the major factors driving the Others segment growth. According to a study published by Global Asthma Report in 2018, around 300 million people across the world suffer from asthma and its impact can be severe if not treated on time.
Regional Analysis:
North America dominated the global market in 2017. High adoption of advanced technologies, presence of key players and favorable reimbursement policies are some factors responsible for its large share. For instance, in 2014, the U.S FDA approved Enspire HD+ Inhaler System by Bose Corporation that uses compressed air to blow nebulizers instead of canned air used earlier which is a major advantage over other devices available in the market at that time.
Asia Pacific is expected to be one of the fastest growing regions during the forecast period owing to increasing awareness about asthma management and availability of efficient treatment options for respiratory disorders such as Nebulizers & inhalers using compressed air therapy devices along with an increase in healthcare expenditure every year due to rising prevalence rate coupled with government initiatives such as “Hospital Efficient Management†program implemented by Ministry Of Health And Family Welfare (MoHFW) India aimed at reducing hospital stay duration.
Growth Factors:
- Increasing incidence of respiratory diseases: The global Nebulizers and Inhalers market is expected to grow at a CAGR of 5.5% during the forecast period, owing to the increasing incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis.
- Growing demand for portable devices: Portable Nebulizers and Inhalers are witnessing high demand due to their ease-of-use and portability. This is driving the growth of the market segment.
- Rising geriatric population: The global geriatric population is growing at a rapid pace, which in turn is leading to an increase in the prevalence of respiratory diseases among this population group. This is propelling the growth of the Nebulizers and Inhalers market worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nebulizers and Inhalers Market Research Report
By Type
Nebulizers, Inhalers
By Application
COPD, Cystic Fibrosis, Asthma, Others
By Companies
PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips Respironics, Yuwell, Leyi, Folee, Medel S.p.A, Briggs Healthcare, 3A Health Care, PARI GmbH
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
225
Number of Tables & Figures
158
Customization Available
Yes, the report can be customized as per your need.
Global Nebulizers and Inhalers Market Report Segments:
The global Nebulizers and Inhalers market is segmented on the basis of:
Types
Nebulizers, Inhalers
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
COPD, Cystic Fibrosis, Asthma, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- PARI GmbH
- Omron
- Drive DeVilbiss Healthcare
- Philips Respironics
- Yuwell
- Leyi
- Folee
- Medel S.p.A
- Briggs Healthcare
- 3A Health Care
- PARI GmbH
Highlights of The Nebulizers and Inhalers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nebulizers
- Inhalers
- By Application:
- COPD
- Cystic Fibrosis
- Asthma
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nebulizers and Inhalers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nebulizers and inhalers are devices that use a gas to atomize medication and deliver it directly to the lungs.
Some of the major companies in the nebulizers and inhalers market are PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips Respironics, Yuwell, Leyi, Folee, Medel S.p.A, Briggs Healthcare, 3A Health Care, PARI GmbH.
The nebulizers and inhalers market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nebulizers and Inhalers Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nebulizers and Inhalers Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nebulizers and Inhalers Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nebulizers and Inhalers Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nebulizers and Inhalers Market Size & Forecast, 2018-2028
4.5.1 Nebulizers and Inhalers Market Size and Y-o-Y Growth
4.5.2 Nebulizers and Inhalers Market Absolute $ Opportunity
Chapter 5 Global Nebulizers and Inhalers Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Nebulizers and Inhalers Market Size Forecast by Type
5.2.1 Nebulizers
5.2.2 Inhalers
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Nebulizers and Inhalers Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Nebulizers and Inhalers Market Size Forecast by Applications
6.2.1 COPD
6.2.2 Cystic Fibrosis
6.2.3 Asthma
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nebulizers and Inhalers Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nebulizers and Inhalers Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Nebulizers and Inhalers Analysis and Forecast
9.1 Introduction
9.2 North America Nebulizers and Inhalers Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Nebulizers and Inhalers Market Size Forecast by Type
9.6.1 Nebulizers
9.6.2 Inhalers
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Nebulizers and Inhalers Market Size Forecast by Applications
9.10.1 COPD
9.10.2 Cystic Fibrosis
9.10.3 Asthma
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Nebulizers and Inhalers Analysis and Forecast
10.1 Introduction
10.2 Europe Nebulizers and Inhalers Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Nebulizers and Inhalers Market Size Forecast by Type
10.6.1 Nebulizers
10.6.2 Inhalers
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Nebulizers and Inhalers Market Size Forecast by Applications
10.10.1 COPD
10.10.2 Cystic Fibrosis
10.10.3 Asthma
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Nebulizers and Inhalers Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Nebulizers and Inhalers Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Nebulizers and Inhalers Market Size Forecast by Type
11.6.1 Nebulizers
11.6.2 Inhalers
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Nebulizers and Inhalers Market Size Forecast by Applications
11.10.1 COPD
11.10.2 Cystic Fibrosis
11.10.3 Asthma
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Nebulizers and Inhalers Analysis and Forecast
12.1 Introduction
12.2 Latin America Nebulizers and Inhalers Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Nebulizers and Inhalers Market Size Forecast by Type
12.6.1 Nebulizers
12.6.2 Inhalers
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Nebulizers and Inhalers Market Size Forecast by Applications
12.10.1 COPD
12.10.2 Cystic Fibrosis
12.10.3 Asthma
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Nebulizers and Inhalers Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Nebulizers and Inhalers Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Nebulizers and Inhalers Market Size Forecast by Type
13.6.1 Nebulizers
13.6.2 Inhalers
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Nebulizers and Inhalers Market Size Forecast by Applications
13.10.1 COPD
13.10.2 Cystic Fibrosis
13.10.3 Asthma
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nebulizers and Inhalers Market: Competitive Dashboard
14.2 Global Nebulizers and Inhalers Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 PARI GmbH
14.3.2 Omron
14.3.3 Drive DeVilbiss Healthcare
14.3.4 Philips Respironics
14.3.5 Yuwell
14.3.6 Leyi
14.3.7 Folee
14.3.8 Medel S.p.A
14.3.9 Briggs Healthcare
14.3.10 3A Health Care
14.3.11 PARI GmbH
